ERBB2 and breast cancer: Based on this idea, combined treatments of breast cancer cell lines in vitro with Th1 cytokines TNF-α and IFN-γ may cause oncogene inactivation of HER2 and subsequent senescence and apoptosis (Braumüller et al., 2013; Namjoshi et al., 2016).